English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52743453    Online Users :  711
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"shih i m"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 51-75 of 78  (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-03-05T12:32:52Z Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A Wu C.H.; TSUI-LIEN MAO; Vang R.; Ayhan A.; Wang T.-L.; Kurman R.J.; Shih I.-M.
臺大學術典藏 2020-03-05T12:32:52Z Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma Guan B.; TSUI-LIEN MAO; Panuganti P.K.; Kuhn E.; Kurman R.J.; Maeda D.; Chen E.; Jeng Y.-M.; Wang T.-L.; Shih I.-M.
臺大學術典藏 2020-03-05T12:32:51Z Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma Ayhan A.; TSUI-LIEN MAO; Seckin T.; Wu C.-H.; Guan B.; Ogawa H.; Futagami M.; Mizukami H.; Yokoyama Y.; Kurman R.J.; Shih I.-M.
臺大學術典藏 2020-03-05T12:32:50Z The roles of ARID1A in gynecologic cancer TSUI-LIEN MAO; Shih I.-M.
臺大學術典藏 2020-03-05T12:32:50Z Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma TSUI-LIEN MAO; Ardighieri L.; Ayhan A.; Kuo K.-T.; Wu C.-H.; Wang T.-L.; Shih I.-M.
臺大學術典藏 2020-03-05T12:32:48Z CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis Ayhan A.; Kuhn E.; Wu R.-C.; Ogawa H.; Bahadirli-Talbott A.; TSUI-LIEN MAO; Sugimura H.; Shih I.-M.; Wang T.-L.
臺大學術典藏 2020-03-05T07:52:42Z Power of the eternal youth: Nanog expression in the gestational choriocarcinoma Shih I.-M.; KUAN-TING KUO
臺大學術典藏 2020-03-05T07:52:40Z Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas (Cancer Research (2009) 69, (4036-42)) KUAN-TING KUO; Guan B.; Feng Y.; Mao T.-L.; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L.
臺大學術典藏 2020-03-05T07:52:39Z DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma KUAN-TING KUO; Mao T.-L.; Chen X.; Feng Y.; Nakayama K.; Wang Y.; Glas R.; Ma M.J.; Kurman R.J.; Shih I.-M.; Wang T.-L.
臺大學術典藏 2020-03-05T07:52:38Z Somatic mutations of PPP2R1A in ovarian and uterine carcinomas Wang T.-L.; Kurman R.J.; Velculescu V.E.; Kuhn E.; Jones S.; KUAN-TING KUO; Mao T.-L.; Panuganti P.K.; Shih I.-M.
臺大學術典藏 2020-03-05T07:52:37Z Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses Shih I.-M.; Wang T.-L.; Levine D.A.; Kurman R.J.; Olvera N.; Shaw P.; Clarke B.; Nakayama K.; KUAN-TING KUO; Wei L.; Roden R.B.S.; Yuan X.; Song L.; Kuhn E.; Wu R.-C.; Guan B.; Wu G.; Zhang J.; Wang Y.
臺大學術典藏 2020-03-05T07:52:35Z Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma Mao T.-L.; Ardighieri L.; Ayhan A.; KUAN-TING KUO; Wu C.-H.; Wang T.-L.; Shih I.-M.
臺大學術典藏 2020-03-03T03:06:51Z Generation and characterization of an ascitogenic mesothelin-expressing tumor model Cheng W.-F.;Hung C.-F.;Chai C.-Y.;Chen C.-A.;Lee C.-N.;Su Y.-N.;Wen-Yih Tseng;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C.; Cheng W.-F.; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; WEN-YIH TSENG; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C.
臺大學術典藏 2020-02-14T02:50:07Z Generation and characterization of an ascitogenic mesothelin-expressing tumor model Wu T.-C.; Wang T.-L.; Shih I.-M.; Hsieh C.-Y.; Tseng W.-Y.I.; Su Y.-N.; Lee C.-N.; Chen C.-A.; Chai C.-Y.; Hung C.-F.; WEN-FANG CHENG; Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Chen C.-A.;Lee C.-N.;Su Y.-N.;Tseng W.-Y.I.;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C.
臺大學術典藏 2020-02-12T04:06:10Z Generation and characterization of an ascitogenic mesothelin-expressing tumor model Wu T.-C.;Wang T.-L;Shih I.-M;Hsieh C.-Y;Tseng W.-Y.I;Su Y.-N;CHIEN-NAN LEE;Chen C.-A;Chai C.-Y;Hung C.-F;Cheng W.-F; Cheng W.-F; Hung C.-F; Chai C.-Y; Chen C.-A; CHIEN-NAN LEE; Su Y.-N; Tseng W.-Y.I; Hsieh C.-Y; Shih I.-M; Wang T.-L; Wu T.-C.
臺大學術典藏 2020-02-06T05:22:24Z Generation and characterization of an ascitogenic mesothelin-expressing tumor model Wu T.-C.;Wang T.-L.;Shih I.-M.;Hsieh C.-Y.;Tseng W.-Y.I.;Su Y.-N.;Lee C.-N.;Chen C.-A.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C.
臺大學術典藏 2020-01-22T07:50:45Z Generation and characterization of an ascitogenic mesothelin-expressing tumor model Cheng W.-F.;Hung C.-F.;Chai C.-Y.;Chi-An Chen;Lee C.-N.;Su Y.-N.;Tseng W.-Y.I.;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C.; Cheng W.-F.; Hung C.-F.; Chai C.-Y.; CHI-AN CHEN; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C.
臺大學術典藏 2017 CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis Wang T.-L.; Shih I.-M.; Sugimura H.; TSUI-LIEN MAO; Bahadirli-Talbott A.; Ogawa H.; Wu R.-C.; Kuhn E.; Ayhan A.; Ayhan A.;Kuhn E.;Wu R.-C.;Ogawa H.;Bahadirli-Talbott A.;Tsui-Lien Mao;Sugimura H.;Shih I.-M.;Wang T.-L.
國立臺灣大學 2015 INCREASED PROLIFERATION IN AH/EIN WITH CONCURRENT INACTIVATION OF ARID1A AND PTEN TUMOR SUPPRESSORS Ayhan, A.; Mao, T. L.; Rahmanto, Y. Suryo; Zeppernix, F.; Wu, R. C.; Wang, T. L.; Shih, I. M.; 毛翠蓮
臺大學術典藏 2015 Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors Ayhan A.; TSUI-LIEN MAO; Suryo Rahmanto Y.; Zeppernick F.; Ogawa H.; Wu R.-C.; Wang T.-L.; Shih I.-M.
臺大學術典藏 2012 Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma Ayhan A.; TSUI-LIEN MAO; Seckin T.; Wu C.-H.; Guan B.; Ogawa H.; Futagami M.; Mizukami H.; Yokoyama Y.; Kurman R.J.; Shih I.-M.
臺大學術典藏 2010 Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma Shih I.-M.; Yano T.; Taketani Y.; Fukayama M.; Nakagawa S.; Maeda D.; TSUI-LIEN MAO; Maeda D.;Tsui-Lien Mao;Fukayama M.;Nakagawa S.;Yano T.;Taketani Y.;Shih I.-M.
臺大學術典藏 2009 IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype Köbel M.; Xu H.; Gilks C.B.; Bourne P.A.; Spaulding B.O.; Shih I.-M.; TSUI-LIEN MAO; Soslow R.A.; Ewanowich C.A.; Kalloger S.E.; Mehl E.; Lee C.-H.; Huntsman D.
臺大學術典藏 2009 Analysis of DNA copy number alterations in Ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas KUAN-TING KUO; Guan B.; Feng Y.; Mao T.-L.; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L.
臺大學術典藏 2009 Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma KUAN-TING KUO; Mao T.-L.; Jones S.; Veras E.; Ayhan A.; Wang T.-L.; Glas R.; Slamon D.; Velculescu V.E.; Kuman R.J.; Shih I.-M.

Showing items 51-75 of 78  (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page